                         SEQUENCE LISTING

<110>  VANDERBILT UNIVERSITY
 
<120>  COMPOSITIONS AND METHODS FOR TREATING INFECTIONS

<130>  20004.0116

<150>  US 61/590,595
<151>  2012-01-25

<160>  6     

<170>  PatentIn version 3.5

<210>  1
<211>  26
<212>  PRT
<213>  ARTIFICIAL SEQUENCE

<220>
<223>  SYNTHETIC CONSTRUCT

<400>  1

Ala Ala Val Ala Leu Leu Pro Ala Val Leu Leu Ala Leu Leu Ala Pro 
1               5                   10                  15      


Val Gln Arg Lys Arg Gln Lys Leu Met Pro 
            20                  25      


<210>  2
<211>  29
<212>  PRT
<213>  ARTIFICIAL SEQUENCE

<220>
<223>  SYNTHETIC CONSTRUCT

<400>  2

Ala Ala Val Ala Leu Leu Pro Ala Val Leu Leu Ala Leu Leu Ala Pro 
1               5                   10                  15      


Cys Tyr Val Gln Arg Lys Arg Gln Lys Leu Met Pro Cys 
            20                  25                  


<210>  3
<211>  28
<212>  PRT
<213>  ARTIFICIAL SEQUENCE

<220>
<223>  SYNTHETIC CONSTRUCT

<400>  3

Ala Ala Val Ala Leu Leu Pro Ala Val Leu Leu Ala Leu Leu Ala Pro 
1               5                   10                  15      


Cys Val Gln Arg Lys Arg Gln Lys Leu Met Pro Cys 
            20                  25              


<210>  4
<211>  28
<212>  PRT
<213>  ARTIFICIAL SEQUENCE

<220>
<223>  SYNTHETIC CONSTRUCT

<400>  4

Ala Ala Val Ala Leu Leu Pro Ala Val Leu Leu Ala Leu Leu Ala Pro 
1               5                   10                  15      


Cys Val Gln Arg Asp Glu Gln Lys Leu Met Pro Cys 
            20                  25              


<210>  5
<211>  8
<212>  PRT
<213>  Influenza A virus

<400>  5

Thr Lys Arg Ser Tyr Glu Gln Met 
1               5               


<210>  6
<211>  10
<212>  PRT
<213>  Homo sapiens

<400>  6

Val Gln Arg Lys Arg Gln Lys Leu Met Pro 
1               5                   10  


